feed,title,long_url,short_url
MarketWatch,Guggenheim downgrades Biogen to neutral from buy after U.S. proposes limiting access to Alzheimer's drug,http://www.marketwatch.com/news/story/guggenheim-downgrades-biogen-neutral-buy/story.aspx?guid=%7B0F9EB7FF%2D5815%2D4757%2DACA3%2D858613F41805%7D&siteid=rss,https://on.mktw.net/3GsTr1X
